1245 related articles for article (PubMed ID: 31088477)
1. A robust six-gene prognostic signature for prediction of both disease-free and overall survival in non-small cell lung cancer.
Zuo S; Wei M; Zhang H; Chen A; Wu J; Wei J; Dong J
J Transl Med; 2019 May; 17(1):152. PubMed ID: 31088477
[TBL] [Abstract][Full Text] [Related]
2. A Robust 8-Gene Prognostic Signature for Early-Stage Non-small Cell Lung Cancer.
He R; Zuo S
Front Oncol; 2019; 9():693. PubMed ID: 31417870
[No Abstract] [Full Text] [Related]
3. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
4. Identification and Validation of a Tumor Microenvironment-Related Gene Signature for Prognostic Prediction in Advanced-Stage Non-Small-Cell Lung Cancer.
Zhang X; Shi X; Zhao H; Jia X; Yang Y
Biomed Res Int; 2021; 2021():8864436. PubMed ID: 33860055
[TBL] [Abstract][Full Text] [Related]
5. A potential signature of eight long non-coding RNAs predicts survival in patients with non-small cell lung cancer.
Zhou M; Guo M; He D; Wang X; Cui Y; Yang H; Hao D; Sun J
J Transl Med; 2015 Jul; 13():231. PubMed ID: 26183581
[TBL] [Abstract][Full Text] [Related]
6. Combined eight-long noncoding RNA signature: a new risk score predicting prognosis in elderly non-small cell lung cancer patients.
Miao R; Ge C; Zhang X; He Y; Ma X; Xiang X; Gu J; Fu Y; Qu K; Liu C; Wu Q; Lin T
Aging (Albany NY); 2019 Jan; 11(2):467-479. PubMed ID: 30659574
[TBL] [Abstract][Full Text] [Related]
7. Prognostic and predictive value of a malignancy-risk gene signature in early-stage non-small cell lung cancer.
Chen DT; Hsu YL; Fulp WJ; Coppola D; Haura EB; Yeatman TJ; Cress WD
J Natl Cancer Inst; 2011 Dec; 103(24):1859-70. PubMed ID: 22157961
[TBL] [Abstract][Full Text] [Related]
8. A large cohort study identifying a novel prognosis prediction model for lung adenocarcinoma through machine learning strategies.
Li Y; Ge D; Gu J; Xu F; Zhu Q; Lu C
BMC Cancer; 2019 Sep; 19(1):886. PubMed ID: 31488089
[TBL] [Abstract][Full Text] [Related]
9. Molecular gene signature and prognosis of non-small cell lung cancer.
Huang P; Cheng CL; Chang YH; Liu CH; Hsu YC; Chen JS; Chang GC; Ho BC; Su KY; Chen HY; Yu SL
Oncotarget; 2016 Aug; 7(32):51898-51907. PubMed ID: 27437769
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of endoplasmic reticulum stress-related eight-gene signature for predicting the overall survival of lung adenocarcinoma.
Lin L; Zhang W
Transl Cancer Res; 2022 Jul; 11(7):1909-1924. PubMed ID: 35966313
[TBL] [Abstract][Full Text] [Related]
11. A novel 12-gene signature as independent prognostic model in stage IA and IB lung squamous cell carcinoma patients.
Wang K; Li Y; Wang J; Chen R; Li J
Clin Transl Oncol; 2021 Nov; 23(11):2368-2381. PubMed ID: 34028782
[TBL] [Abstract][Full Text] [Related]
12. A Six-Gene Signature Predicts Survival of Adenocarcinoma Type of Non-Small-Cell Lung Cancer Patients: A Comprehensive Study Based on Integrated Analysis and Weighted Gene Coexpression Network.
Xie H; Xie C
Biomed Res Int; 2019; 2019():4250613. PubMed ID: 31886214
[No Abstract] [Full Text] [Related]
13. Identification of a 4-lncRNA signature predicting prognosis of patients with non-small cell lung cancer: a multicenter study in China.
Wang RQ; Long XR; Ge CL; Zhang MY; Huang L; Zhou NN; Hu Y; Li RL; Li Z; Chen DN; Zhang LJ; Wen ZS; Mai SJ; Wang HY
J Transl Med; 2020 Aug; 18(1):320. PubMed ID: 32819367
[TBL] [Abstract][Full Text] [Related]
14. A signature of tumor immune microenvironment genes associated with the prognosis of non‑small cell lung cancer.
Li J; Li X; Zhang C; Zhang C; Wang H
Oncol Rep; 2020 Mar; 43(3):795-806. PubMed ID: 32020214
[TBL] [Abstract][Full Text] [Related]
15. A highly expressed mRNA signature for predicting survival in patients with stage I/II non-small-cell lung cancer after operation.
Ma N; Si L; Yang M; Li M; He Z
Sci Rep; 2021 Mar; 11(1):5855. PubMed ID: 33712694
[TBL] [Abstract][Full Text] [Related]
16. Identification of a novel gene expression signature associated with overall survival in patients with lung adenocarcinoma: A comprehensive analysis based on TCGA and GEO databases.
Zhao J; Guo C; Ma Z; Liu H; Yang C; Li S
Lung Cancer; 2020 Nov; 149():90-96. PubMed ID: 33002836
[TBL] [Abstract][Full Text] [Related]
17. Development and Validation of an Individualized Immune Prognostic Signature in Early-Stage Nonsquamous Non-Small Cell Lung Cancer.
Li B; Cui Y; Diehn M; Li R
JAMA Oncol; 2017 Nov; 3(11):1529-1537. PubMed ID: 28687838
[TBL] [Abstract][Full Text] [Related]
18. KRAS driven expression signature has prognostic power superior to mutation status in non-small cell lung cancer.
Nagy Á; Pongor LS; Szabó A; Santarpia M; Győrffy B
Int J Cancer; 2017 Feb; 140(4):930-937. PubMed ID: 27859136
[TBL] [Abstract][Full Text] [Related]
19. A innovative prognostic symbol based on neutrophil extracellular traps (NETs)-related lncRNA signature in non-small-cell lung cancer.
Fang C; Liu F; Wang Y; Yuan S; Chen R; Qiu X; Qian X; Zhang X; Xiao Z; Wang Q; Fu B; Li Y
Aging (Albany NY); 2021 Jul; 13(13):17864-17879. PubMed ID: 34257164
[TBL] [Abstract][Full Text] [Related]
20. Identification of a multidimensional transcriptome signature for survival prediction of postoperative glioblastoma multiforme patients.
Gao WZ; Guo LM; Xu TQ; Yin YH; Jia F
J Transl Med; 2018 Dec; 16(1):368. PubMed ID: 30572911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]